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Abstract 
Great efforts have been made to develop robust signal-generating fluorescence materials which 
will help in improving the rapid diagnostic test (RDT) in terms of sensitivity and quantification. In 
this study, we developed coumarin-derived dendrimer-based  fluorescent  immunochromato-
graphic strip test (FICT) assay with enhanced sensitivity as a quantitative diagnostic tool in typical 
RDT environments. The accuracy of the proposed FICT was compared with that of dot blot 
immunoassay  techniques  and conventional RDTs.  Through conjugation of coumarin-derived 
dendrimers with latex beads, fluorescent emission covering broad output spectral ranges was 
obtained which provided a distinct advantage of easy discrimination of the fluorescent emission of 
the latex beads with a simple insertion of a long-pass optical filter away from the excitation 
wavelength. The newly developed FICT assay was able to detect 100 ng/10 µL of influenza A nu-
cleoprotein (NP) antigen within 5 minutes, which corresponded to 2.5-fold higher sensitivity than 
that of the dot blot immunoassay or conventional RDTs. Moreover, the FICT assay was confirmed 
to detect at least four avian influenza A subtypes (H5N3, H7N1, H7N7, and H9N2). On applying 
the FICT to the clinical swab samples infected with respiratory viruses, our FICT assay was con-
firmed to differentiate influenza H1N1 infection from other respiratory viral diseases. These data 
demonstrate that the proposed FICT assay is able to detect zoonotic influenza A viruses with a 
high sensitivity, and it enables the quantitation of the infection intensity by providing the numerical 
diagnostic values; thus demonstrating enhanced detectability of influenza A viruses. 
Key words: Avian influenza A subtype, Fluorescent immunochromatographic strip test (FICT), 
Conjugation, Latex, Coumarin-derived dendrimer, Dot blot immunoassay. 
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Introduction 
Influenza viruses are categorized into three 
types, A, B, and C based on the antigenicity of the 
nucleoprotein (NP),  and  influenza A viruses are 
causative agents of influenza, a contagious respiratory 
viral disease in a wide variety of animals such as 
humans, birds, and poultry [1-3].  H1N1, known as 
influenza virus or swine flu, was generated by com-
bination of genes from human and pigs, and the out-
break  occurred  in Mexico, causing a  devastating 
worldwide pandemic [4]. Human infections with in-
fluenza viruses derived directly from wild birds or 
poultry are rare, but, recently, over 600 human infec-
tions by influenza A (H5N1) viruses have been de-
tected as fatal cases [5]. Upon contact with infected 
poultry, influenza A (H7) virus infections have also 
occurred in humans, causing general respiratory 
symptoms and one case of death [6-8]. However, in 
March 2013, human infections with a novel avian in-
fluenza  A  (H7N9) virus resulted in a number of 
deaths [9]. Avian H9N2 influenza A virus has caused 
repeated human infections in Asia [10]. Because in-
fluenza A viruses are responsible for the occasional 
global influenza pandemics in human populations 
due to the increased number of viruses crossing the 
animal-human host species barrier, it causes a signif-
icant impact on animal and human health, and hence, 
systematic surveillance is required [11]. Therefore, it is 
essential to timely screen for avian- and human in-
fluenza A viruses by monitoring at least three prom-
inent subtypes of avian influenza A viruses (H5, H7, 
and H9). As a result, rapidity in detecting the pres-
ence of influenza A virus during the acute phase of 
infection is crucial for  providing immediate clinical 
treatment and sequestering procedures [12]. To detect 
influenza virus, viral culture, enzyme-linked im-
munosorbent assay (ELISA), fluorescence immuno-
assay,  and  polymerase chain reaction (PCR) tech-
niques are mainly used in hospitals and laboratories 
[13]. However, these techniques require well-trained 
technicians and delicate lab equipments. Due to the 
test speed, portability, and ease of performance, im-
munoassay utilizing monoclonal antibody is com-
monly used in many hospital laboratories, emergency 
departments, and doctors' offices, and commercially 
available rapid influenza diagnostic tests (RIDTs) that 
detect the influenza virus NP antigen are widely used 
in clinical practice for diagnosing influenza [14, 15]. 
Despite its many advantages such as low cost, cell 
culture free, and easy field application, the use of the 
conventional RDT as a screening tool is limited be-
cause of variable sensitivities for detection of influ-
enza A viruses [16-18].  It  was confirmed that there 
were 29/1,346 (2.2%) discordant test results between 
the automated reader and the visual interpretation of 
RDTs [19]. As an alternative for identifying proteins 
derived from a target influenza virus, there is a strong 
demand for a highly sensitive diagnostic system that 
can detect and characterize influenza virus  in  na-
noscale objects [20]. In recent years, for further im-
proved sensitivity of influenza A detection, viral de-
tection systems including magnetic bead-, nanoparti-
cle-, and fluorescence-based assays have been intro-
duced by several groups [12, 21-23]. However, they 
still present a challenge of integration of rapid 
screening method upon advancement of viral detec-
tion systems for field application. Among the above 
mentioned  advanced viral detection systems, fluo-
rescent materials act as powerful labels in developing 
innovative immunoassays for influenza A virus [24, 
25]. Previously, coumarin-derived dendrimers, novel 
fluorescence materials excitable by light emitting di-
odes (LEDs), were confirmed as potential candidates 
for diagnosing malaria infection with higher perfor-
mance of fluorescence-linked immunosorbent assay 
(FLISA)  than ELISA [26]. Herein, we developed  an 
innovative method that applies the coumarin-derived 
dendrimers to the influenza A RIDTs for quantifica-
tion of diagnostic values through an  LED-based 
portable strip reader; thus establishing a highly sensi-
tive fluorescent  immunochromatographic  strip  test 
(FICT). In this study, coumarin-derived dendrimers 
were integrated into the influenza A RIDTs for tar-
geting the influenza A NP which is abundant in in-
fluenza A virus, and the fluorescence intensities were 
determined to detect the presence of avian and human 
influenza A viruses.  
Experimental 
Materials and Reagents 
Aliphatic Amine Latex Beads (2% w/v, 20 nm) 
were purchased from Life technology and influenza A 
NP protein was purchased from Novus Biologicals. 
As two monoclonal antibodies (mAb) for the FICT, 
anti-influenza A -7307 and -7304 were purchased from 
Medix  Biochemica.  Aqueous glutaraldehyde  (8% in 
DW)  solution  and goat anti-mouse IgG were pur-
chased from Sigma-Aldrich.  
Viruses 
Professor Du-young Choi (Wonkwang Univer-
sity, Korea) kindly provided H1N1- and other respir-
atory virus-infected patient samples. Professor Haan 
Woo Sung  (Kangwon National University,  Korea) 
kindly provided avian influenza viruses (H5N3, 
H7N1, H7N7, and H9N2)-infected samples (Table 1).  
Egg inoculation for virus culture and 
purification 
Hemagglutination assay (HA) was performed to  Theranostics 2014, Vol. 4, Issue 12 
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assess the viral titer before virus amplification. Briefly, 
50 μL of PBS was added to a round-bottomed 96-well 
plate and an equivalent volume of diluted virus solu-
tion was added and after mixing it well; then, 50 μL of 
the mixture was transferred to the next consecutive 
well. Equal volume of 0.5% red blood cells was added 
to the diluted virus solution, and cells were plated at 
room temperature (RT) before reading the agglutina-
tion test result. For determining the propagation of 
influenza viruses including avian influenza viruses 
(H5N3, H7N1, H7N7, and H9N2) and pa-
tient-collected  swabs  (H1N1), supernatant (50 
HAU/0.1 mL) of the influenza virus was inoculated 
into the allantoic cavity of 9- to 11-day-old embryo-
nated eggs. After 2 days, the allantoic fluid was col-
lected and titrated by HA. Purification of influenza 
virus was performed as previously described [27]. 
Briefly, the allantoic fluid was subjected to centrifu-
gation (2600×g, Centrifuge 5804R, Eppendorf, Ger-
many) at 4 °C for 5 min. After centrifugation, the su-
pernatant was layered over a 20% sucrose cushion in 
NTE buffer (100 mM NaCl, 10 mM Tris-HCl (pH 7.4), 
1 mM EDTA), following concentration by ultracen-
trifugation (112,600×g, 2 hours, a SW28 rotor (Beck-
man Coulter, Fullerton, California)). Precipitated 
protein was dissolved in PBS and subjected to HA 
titration for further Dot blot and FICT assays. 
 
Table 1. Characterization of four avian influenza virus subtypes. 
Name of avian influenza virus  Sub-
type 
Location of 
solation 
Host for 
isolation 
Ya-Lake ChungCho 
10-3-F1(2011) 
H5N3  Lake of 
ChungCho, 
Sokcho, Korea 
Wild avian 
mallard 
Ya-Jeju, Youngsoori-12-2F4(2012) 
A/common teal/Korea/KNU 
YSR12/2012(H7N1) 
H7N1  Jeju, Korea  Wide-
spread 
common 
teal 
Ya-Lake Kyungpo 
-12-2-F3(2011) 
A/mallard/Korea/KNU 
GPH12/2011(H7N7) 
H7N7  Lake of 
Kyungpo, 
Kangrung, 
Korea 
Wild avian 
mallard 
Jae-Songwoorijang-chicken-TR-TR 
A/chicken/Korea/KNUSWR09/2009
(H9N2) 
H9N2  Pochun, 
Korea 
Traditional 
market 
chicken 
 
 
Diagnostic strip and portable strip reader 
For  the  FICT, nitrocellulose membrane (EMD 
Millipore, Darmstadt, Germany) was used for antibody 
coating. The membrane was coated with 0.2 µg of goat 
anti-mouse IgG (Life Technology) on the control line 
and 0.8 µg of anti-influenza A NP on the test line re-
spectively. After drying the membrane at 30 °C for 
two hours, the diagnostic strip was tested for FICT 
assay. A portable strip reader with a 450 nm LED, an 
optical filter with  590 nm  wavelength, an optical 
spectrometer, and a stroller to load the diagnostic 
strip, was kindly provided by Dr. Chom-Kyu Chong
 
(GenBody, Korea).  
Preparation of latex beads conjugated with 
coumarin-derived dendrimer and antibody  
Coumarin-derived dendrimer was provided by 
Professor  Hak-Sung Kim (Wonkwang University, 
Korea) and characterized previously [28]. For covalent 
conjugation of mAb with latex and coumarin-derived 
dendrimer, 0.8 mL of aliphatic amine latex beads (20 
nm) were washed with PBS (pH 7.4) and in the pres-
ence of 0.8 mL conjugation buffer (0.1 M sodium bi-
carbonate, pH 8.5), 128 µL of coumarin-derived den-
drimer (1 mg/mL in DMSO) was added to latex in the 
conjugation buffer at RT for 1 hour with shaking. Af-
ter washing the latex beads twice with PBS, couma-
rin-derived dendrimer-conjugated latex beads were 
resuspended with 0.8  ml of anti-influenza A NP (1 
mg/mL) and incubated at 4 ºC. After one hour, glu-
taraldehyde (0.5 mL) was slowly added to the mixture 
of latex and antibody and it was vortexed well for 1 
minute.  After vortexing, the  conjugate mixture was 
incubated at 4 ºC for 2 hours with shaking and then 
washed with PBS twice. The precipitated bioconju-
gates were resuspended in 1 mL of 0.1% bovine serum 
albumin (BSA) (Sigma), making 0.8 mg/mL of mAb 
on the latex surface and it was stored at 4 °C.  
Dot blot immunoassay 
The polyvinylidene fluoride (PVDF) membrane 
(Millipore)  was  spotted  with  10  μL  of  diluted vi-
rus-infected samples on the surface and dried at 37 °C 
for 90 minutes. After complete drying, the membrane 
was blocked with 5% non-fat dried milk in PBST (PBS, 
0.1% Tween 20) for 1 hour. The blocked membrane 
was incubated with a primary antibody (1 µg/mL) in 
5% BSA  for 16 hours at 4  °C. After washing the 
membrane  with PBST three times, horseradish pe-
roxidase (HRP)-conjugated anti-mouse IgG (Life 
technology) was applied to the membrane and the 
membrane was incubated at RT for 1 hour at a mild 
shaking speed. Finally,  the  membrane was washed 
with PBST three times and chemiluminescence was 
detected within 1 minute by applying ECL substrate 
(Bio-Rad) to the membrane. 
FICT and RDT 
After application of 10 µL of the bioconjugate to 
the conjugate pad in the diagnostic strip, 10 µL swab 
samples or diluted viral antigens were applied to the 
diagnostic strip and 100 µL sample diluent buffer (25 
mM HEPES (pH 7.5), 100 mM NaCl, 2.5 mM MgCl2, 
0.1% NP40) was added to the samples. The diagnostic 
strip was kept in a dark place for 5 minutes, and the  Theranostics 2014, Vol. 4, Issue 12 
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fluorescent intensity was measured quantitatively by 
the portable strip reader. To compare the performance 
of FICT with  that of RDT,  a commercialized  RDT 
(Humasis, Korea) was  used in this study. Equal 
amount of swab samples and viral solutions were 
used for the RDT in the presence of sample buffer, 
and it was read with the naked eye within 15 minutes.  
Measurement of the spectroscopic properties 
of coumarin-derived dendrimer latex 
bioconjugate  
An ultraviolet/visible spectrometer (Optizen 
Pop, Mecasys, Korea) and a spectral scanning multi-
mode reader (Varioskan Flash, Thermo Electron 
Corporation, USA) were used to measure the absorp-
tion and emission spectra, respectively. During each 
measurement, the sample solution was illuminated by 
the excitation light, and the absorption/emission 
spectra were subsequently measured by the spec-
trometer at RT. The integration time varied according 
to the sample concentration. A deuterium/tungsten 
lamp was used for absorption  measurements. The 
emission spectra were obtained with a filtered Xenon 
flash lamp whose peak wavelength was 450 nm. 
Ethical considerations 
The study was approved by  the Institutional 
Review Board of the Wonkwang University Hospital 
(Approval No. 1263). 
 
Results and Discussion 
Working principle of the FICT diagnostic assay 
Figure 1 illustrates the  scheme of  quantitative 
FICT assay, using immunochromatographic strip test 
(ICT). The ICT is the simplest and commercial rapid 
diagnostic tool [29]. As a point-of-care diagnostic tool, 
it is important that it plays a role in generating and 
transducing the signal in an immunoassay, which 
determines the performance of ICT for quantification 
in addition to high sensitivity [30]. Recently, to de-
velop signals in the ICT, many advanced candidates 
such as latex particles and organic fluorophores have 
been explored to adapt to the  rapid diagnostic test 
strip [31-33]. The test strip for ICT consists of a con-
jugate pad, sample pad, nitrocellulose membrane, and 
absorbent pad. In this study, a quantitative rapid di-
agnostic strip was fabricated using coumarin-derived 
dendrimer-mediated fluorescence material and latex. 
Anti-influenza A nucleoprotein (NP) and anti-mouse 
IgG were coated onto the nitrocellulose membrane 
and the surface-conjugated latex with another mAb of 
influenza  A  NP and coumarin-derived dendrimers 
were pre-loaded on the conjugation pad, completing a 
diagnostic strip. Test zone (T) indicated  the place 
where anti-influenza A NP is coated, and in the ab-
sence of target NP antigens, latex conjugates could not 
react with mAb in the T zone. Whereas in the presence 
of influenza A NP antigens, the lateral  flow of the 
conjugate (latex conju-
gated with an-
ti-influenza A NP and 
coumarin-derived den-
drimers) along the 
membrane  was sup-
posed to be paused in 
the  T zone due to  im-
munoreactivity among 
coating mAb, antigen, 
and conjugated mAb. 
Finally, the fluorescence 
intensity of couma-
rin-derived dendrimers 
was detected by the 
LED-based portable 
strip reader. In the con-
trol zone (C), anti-mouse 
IgG recognized  the an-
ti-influenza NP on the 
surface of latex, provid-
ing the level of lateral 
flow during each test. It 
has been reported that 
the fluorescence inten-
sity ratio between the 
 
Figure 1. Schematic illustration of the FICT assay using RDT strip and portable strip reader. After application of 
clinical samples to RDT, a LED-based portable strip reader and a personal computer quantify the diagnostic values.  
  Theranostics 2014, Vol. 4, Issue 12 
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test zone (T) and the control zone (C) was used to 
determine the amount of analyte in the sample [30], 
and therefore, each T peak value was divided by each 
C peak value to quantify the relative diagnostic value 
in this study. As analytes, four avian influenza A vi-
rus subtypes derived from isolates of wild birds 
(mallard,  common teal, and chicken) and human 
swab samples were loaded onto the sample pad with 
sample lysis buffer. After application, the fluorescence 
intensity was read within 5 minutes in a dark place by 
the LED-based portable strip reader. The excitation 
and detection wavelengths were 450 nm and 590 nm, 
respectively.  
Characterization of conjugation 
N-hydroxysuccinimide (NHS) esters of couma-
rin-derived dendrimers reacted with primary amine 
groups (–NH2) on the latex surface in sodium biocar-
bonate  buffer (pH 8.5) to form stable amide bonds 
upon release of NHS (Figure 2 (a) and (b)). Through 
carboxylates (-COOH) of hydrophilic glutaraldehyde, 
amines (-NH2) on the antibody were conjugated by 
forming the amide bond (Figure 2 (c) and (d)). After 
conjugation, the conjugated mAb on latex was puri-
fied by high speed centrifugation and washing.  
Characteristics of the conjugate 
Fluorescence and immunogenicity of mAb con-
jugated with latex and coumarin-derived dendrimer 
were characterized by dot-blot immunoassay. Fluo-
rescence intensity was observed  under UV-visible 
light or fluorescence with 460 nm excitation and 560 
nm emission was measured by using an Infinite F200 
microplate reader (TECAN, Männedorf, Switzerland). 
After  completing  the conjugation, 0.8 mg/mL mAb 
was anticipated to be conjugated with latex according 
to the mathematical calculation, provided all anti-
bodies reacted with latex to yield covalent conjugates. 
When 4 µg/10 uL of conjugated mAb, 1/2 concentra-
tion of the FICT application, was dotted on the PVDF, 
yellow color of the conjugated mAb was observed by 
the naked eye and under UV visible light. To put it 
simply, the fluorescence intensity was detectable  at 
the spot of conjugated mAb, confirming the fluores-
cence signaling of latex conjugated with mAb and 
coumarin (Figure 3(a)).  
 
 
Figure 2. Schematic diagram of conjugation. Latex was conjugated with glutaraldehyde and antibody by forming amide bonds in biocarbonate buffer (pH 8.5) (a-d).  Theranostics 2014, Vol. 4, Issue 12 
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Figure 3. Characterization of mAb and coumarin-derived dendrimer in the conjugate. After conjugation, fluorescence level of the conjugate was observed with the 
naked eye and UV. The presence of antibody on the surface of latex was investigated with immunoblot (a). The immunoreactivity of mAb after conjugation was confirmed by 
dot-blot immunoassay (b). At day 10, the level of fluorescence emission on latex was compared to that in the original coumarin-derived dendrimers solution with equal 
concentration (c) and stability of conjugate was determined by FICT at 10 days (d and e). Coumarin: coumarin-derived dendrimer, Conjugated Ab: Latex conjugated with mAb 
and coumarin-derived dendrimer, NP: Nucleoprotein. 
 
 
The efficiency of Ab conjugation with latex was 
assessed by comparing with bare or conjugated mAb 
in dot-blot immunoassay. The conjugated mAb and 
unconjugated mAb were applied to the PVDF and the 
chemiluminescence  levels  were  detected by using 
HRP anti-mouse IgG. After screening the amount of 
conjugated mAb on latex by immunoassay, in spite of 
the high fluorescence intensity of conjugated Ab, the 
chemiluminescence signal with conjugated mAb was 
significantly low compared  to  that with bare mAb 
(Figure 3 (b)). The reason for low chemiluminescence 
signaling could be low  reactivity  of  the  secondary 
antibody with the conjugated mAb due to steric hin-
drance of latex or conjugation of few mAbs with latex 
due to low efficiency of covalent binding  [30].  The 
immunoreactive property of conjugated mAb was 
confirmed by using influenza A NP protein and the 
antigen was still detectable by using the conjugated 
mAb. After storing the conjugate at 4 °C for 10 days, 
fluorescence intensity of the conjugate was compared 
with  that of an equal amount of fresh couma-
rin-derived dendrimers. At 10 days, the conjugated 
mAb was still showing a high fluorescence intensity 
of 92.19 ± 5.34 (mean ± SD) % in comparison to the 
fresh latex-free coumarin-derived dendrimer ((Figure 
3 (c)). We performed a FICT assay with 10-day-old 
conjugated mAb and compared it with that of fresh 
conjugate (day 0). The FICT showed a positive value 
at 10-day-old conjugate  (Figure 3 (d) and (e)).  The 
characteristics of the conjugated mAb implicate that 
highly sensitive and stable fluorescence intensity of 
coumarin-derived dendrimer plays an essential role 
in the discernible diagnostic performance of the con-
jugated complex.  Theranostics 2014, Vol. 4, Issue 12 
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Figure 4. Spectral properties of the conjugate. Fluorescence absorption and 
emission spectra were measured and compared under various conjugation scenarios 
in distilled water by 1:1 dilution. The broad wavelength range of fluorescent emission 
spectra from the latex bead conjugate was observed (a). The fluorescence emission 
intensity was influenced by additional mAb conjugation at 550-600 nm (b). In the 
presence of the NP antigen, the fluorescence emission at longer wavelengths was not 
significantly changed (c). 
 
Optical properties (fluorescence absorption 
and emission spectra) of the conjugate and 
antigen 
The optical properties (fluorescence absorption 
and emission spectra) of the latex beads conjugated 
with coumarin-derived dendrimer, mAb, and influ-
enza A NP antigen were examined. The latex beads 
conjugated with coumarin-derived dendrimer only 
(Figure 4A) had a relatively wide absorption wave-
length range with the main peak near 450 nm. The 
addition of mAb (Figure 4 (b)) and antigen (Figure 4 
(c)) did not significantly alter the absorption spectra, 
and the main absorption peak remained near 450 nm. 
Such stable and broad absorption characteristics allow 
the use of broadband light sources, such as light 
emitting diodes, for facile fluorescent excitation. The 
absorption tails at longer wavelengths were mainly 
from the latex bead. The fluorescent emission spectra 
also exhibited wide spectral ranges, and therefore, the 
presence of fluorescent latex beads could be easily 
detected with the emission optical filter (590 nm 
wavelength) as employed in the LED-based portable 
strip reader. This result was also consistent with the 
previous report of coumarin-derived dendrimer 
characterization [28]. 
Comparison of the lowest detectable 
concentration 
For the field application of the point-of-care di-
agnostic tool, it should be easily operated by lay peo-
ple. FICT assay was simply performed by adding 10 
μL  of  the  sample  with additional sample dilution 
buffer on the sample pad. The diagnostic values were 
quickly measured  by  the  LED-based portable strip 
reader. On the basis of the preliminary data, the op-
timal reactive time ranged from 5 to 10 minutes, and 
the reactive time was determined to be 5 minutes in 
this study. The detection sensitivity of the FICT assay 
was determined by analyzing standard influenza A 
NP antigens at a concentration from 10 ng/10 µL to 
500 ng/10 µL. For interpretation of the reactivity in 
the T zone, each T peak value was normalized by each 
C zone because sample migration could vary accord-
ing to the lateral flow. Therefore, the peak value of 
each control zone implies the migration of conjugated 
mAb along the membrane of ICTs. Figure 5 (a) and 5 
(b) show that the T/C ratio derived from each peak of 
fluorescence was enhanced by a gradual increase in 
influenza A NP antigens,  and the detectable mini-
mum concentration of NP antigen was 100 ng/10 µL, 
which was the lowest detectable concentration (LDC) 
of FICT. Despite the nonspecific peak in the T zone in 
FICT, the cut-off values indicated  the positive and 
negative values. In contrast, the LDC of both the 
dot-blot immunoassay and RDT was 250 ng/10  µL, 
indicating that those methods were 2.5-fold less sen-
sitive than the FICT assay (Figure 5 (c)). 
Detection of avian influenza virus subtypes 
Because the conjugated mAb targeted the influ-
enza A NP protein, FICT was also used to detect avian 
influenza A viral particles isolated from wild birds. To 
assess the potential of FICT for  screening  various 
avian  influenza  A subtypes transmissible between 
humans  and  birds, four sequence-confirmed avian 
influenza A subtypes (H5N3, H7N1, H7N7, and 
H9N2) were amplified in fertilized eggs and then pu- Theranostics 2014, Vol. 4, Issue 12 
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rified for further study. Using 40 HAU/10 µL of viral 
antigens, fluorescence intensities of four avian sub-
types (H5N3, H7N1, H7N7, and H9N2) were com-
pared to that of H1N1, and they were found to be 
lower than the fluorescence intensity of H1N1 (Figure 
6 (a) and 6 (b)). Among the 4 subtypes, H7N1 and 
H7N7 showed the highest fluorescence intensity in 
both FICT and dot-blot immunoassay, demonstrating 
a highly correlated performance of these two different 
assays. In Figure 6 (c), the immunoreactivity of 
mAb-NP against H1N1 as well as against four avian 
subtypes was confirmed by dot-blot immunoassay 
and T/C values of FICT against avian influenza vi-
ruses were  highly correlated with those of dot-blot 
immunoassay. Therefore, FICT based on the couma-
rin-derived dendrimer is a reliable, accurate, and 
rapid diagnostic tool for the detection of human and 
avian influenza A viruses. 
 
Figure 5. Comparison of the lowest detectable concentration (LDC) among the FICT assay, Dot blot, and RDT. Influenza virus A nucleoprotein (NP) was 
serially diluted in PBS and applied to the FICT assay. T/C ratio (%) indicated 100 ng/strip as the LDC of the FICT assay (a and b) and 250 (ng/strip/10 µL) as the LDC of both the 
dot blot and RDT (c). 
 
Figure 6. FICT assay for detection of avian influenza virus subtypes. Four avian influenza virus subtypes isolated from several different locations in Korea were tested 
with the FICT assay. The amount of virus was titrated by the HA assay and applied to the FICT assay with 40 HAU/strip (a). T/C ratio (%) indicated that all four subtypes were 
found to be positive with FICT (b) and they were compared with Dot-blot analysis (c).  Theranostics 2014, Vol. 4, Issue 12 
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Clinical evaluation of the FICT assay 
Furthermore, in order to evaluate the potential of 
FICT to detect the influenza virus quantitatively, 
clinical patient samples were assessed  by applying 
FICT. Through the FICT assay, diagnostic values were 
digitized, allowing the user to quantify the diagnostic 
intensity objectively.  The presence of each virus in 
patient samples was confirmed by cell culture and 
PCR. Moreover, the specificity of FICT was confirmed 
with 10 µL solution obtained from neutralizing buff-
ered swab samples (two normal  samples, five 
H1N1-infected  patient samples, and four different 
respiratory virus-infected patient samples). Test zone 
(T) showed higher peak values than the control zone 
(C) peak when H1N1 patients samples were applied 
to FICT, but each peak value of the T zone was lower 
than the peak value of the C zone in negative samples 
as well as in other respiratory virus-infected samples 
(Figure 7 (a)). Each relative value of T/C ratio showed 
the cut-off line between influenza A virus 
(H1N1)-infected samples and negative samples 
(normal and other respiratory viruses) (Figure 7 (b)). 
The quantitative analysis of clinical samples with 
FICT was conducted by preparing a calibration curve 
of HAU titers. The fluorescent values of clinical sam-
ples were incorporated into the standard curve which 
was created with the T/C value (%) of serially diluted 
H1N1 HAU titer  and a linear regression (R2=0.945) 
was used to calculate HAU titers (Figure 7 (c) and (d)). 
In this study, the FICT assay showed a linear range of 
0.625-40 HAU/10 µL for the purified avian influenza 
virus. To compare the range of quantification between 
FICT and RDT, we investigated the quantitative range 
of RDT. As shown  in Figure 7 (e), the quantitative 
range of RDT was 5-40 HAU/10 µL. Using a fluores-
cent–linked immunosorbent assay (FLISA), a linear 
range of quantum-dot-based fluoroimmunoassay has 
been reported as 8-510 ng/mL for the purified H5N1 
virus with polyclonal antibody against H5N1 [34]. 
This method is another experimental work using flu-
orescence probe but due to different experimental 
condition, it is not convenient to compare the per-
formance between the quantum-dot-based FLISA and 
coumarin-derived dendrimer-based FICT. The results 
showed that the sensitivity of quantum-dot-based 
FLISA was 30-fold greater than the conventional 
ELISA and the sensitivity of coumarin-derived den-
drimer-based FICT was 2.5-fold higher than the col-
loidal gold-based RDT. 
 
Figure 7. Clinical evaluation of the FICT assay. H1N1-positive patient samples (n=5) and other respiratory viruses (Metapneumovirus, Adenovirus, Parainfluenza, and 
Respiratory syncytial virus (RSV))-infected swab samples (n=4) and two normal swab samples (n=2) were applied to the FICT assay (a). T/C value (%) in all H1N1 patients were 
above the cut-off line (blue line) (b). Differently diluted H1N1 virus antigens were tested with the FICT assay to provide the calibration curve of the FICT assay (c). Quantitative 
value in H1N1 patients diagnosed as positive by the FICT assay was incorporated in the calibration curve of H1N1 antigen and used for analyzing the HAU titer of clinical samples 
(d). The quantitative range of RDT was determined with the serially diluted H1N1 virus antigen.   Theranostics 2014, Vol. 4, Issue 12 
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Table 2. Comparison of performance of FICT to that of RDT using clinical samples. 
 
 
 
The  HAU titer in  five H1N1-positive patients 
was quantitatively determined as 6.09 ± 0.99, 4.5 ± 0.49 
4.6  ±  1.3,  21.2  ±  3.03,  and  5.1  ±  0.65  (mean  ±  SD) 
HAU/10 uL, respectively and their titers were con-
firmed by HA assay.  
Additionally,  the  diagnostic accuracy of FICT 
was evaluated by comparing  with that of  conven-
tional RDT as described previously [35] (Table 2). The 
FICT performance was highly correlated with culture 
and PCR results; but when the same clinical samples 
were applied to RDT, two negative results were ob-
tained among the five H1N1-positive patients in 10 µL 
of a sample scale. In contrast, with the FICT assay, all 
of the PCR/culture  positive  H1N1 patients were 
found to be positive. Among the three positive sam-
ples in the RDT, a case of influenza A (H1N1-3) was 
rarely diagnosed due to the weak colorimetric result; 
but in the FICT assay, the T/C value (%) was higher 
than the cut-off value. Therefore, FICT was not only 
an accurate but also a quantitative assay for detection 
of influenza A virus infection. 
Conclusion 
The FICT assay for the influenza A virus  was 
developed by combining the  mAb conjugated with 
latex beads and coumarin-derived dendrimers for 
detection of the avian influenza virus and new human 
influenza virus (H1N1). The lowest detectable con-
centration (LDC) of the FICT assay was determined as 
100 ng/10 µL, which was 2.5-fold higher than that of 
the dot blot immunoassay and colloidal gold-based 
rapid diagnostic strips. Moreover, the  FICT assay 
could detect avian influenza virus subtypes (H5N3, 
H7N1, H7N7, and H9N2). On  applying the  clinical 
swab samples infected with respiratory viruses to 
FICT, all of the H1N1-positive patients were found to 
be positive and the enhanced LDC of the FICT assay 
allowed  for diagnosis of H1N1 patients who were 
negative by RDT. Using the  standard H1N1 virus 
antigen,  the  HAU titer of the  influenza virus was 
quantified in all of the patients. In conclusion, a sim-
ple and quantitative diagnostic FICT assay was de-
veloped  for  enhanced  detection of  the  influenza A 
virus, and therefore, this assay proposes to be an in-
novative diagnostic technology for application in 
clinical diagnosis. 
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